Publications

Early Data on Long-Term Efficacy and Safety of Inotersen in Patients with Hereditary Transthyretin Amyloidosis: a 2-Year Update from the Open-Label Extension of the Neuro-Ttr Trial

AuthID
P-00S-YG2

Author(s)

Brannagan, TH

Wang, AK

Coelho, T

Waddington Cruz, MW

Polydefkis, MJ

Dyck, PJ

Plante Bordeneuve, V

Berk, JL

Barroso, F

Merlini, G

Conceicao, I

Hughes, SG

Kwoh, J

Jung, SW

Guthrie, S

Pollock, M

Benson, MD

Gertz, M

Group Author(s)

NEURO TTR Open Label Extens In

Document Type

Article

Year published

2020

Published

in EUROPEAN JOURNAL OF NEUROLOGY, ISSN: 1351-5101

Volume: 27, Issue: 8, Pages: 1374-1381 (8)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1111/ene.14285

Wos: WOS:000536118000001

Source Identifiers

ISSN: 1351-5101

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Early Data on Long-Term Efficacy and Safety of Inotersen in Patients with Hereditary Transthyretin Amyloidosis: a 2-Year Update from the Open-Label Extension of the Neuro-Ttr Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Early Data on Long-Term Efficacy and Safety of Inotersen in Patients with Hereditary Transthyretin Amyloidosis: a 2-Year Update from the Open-Label Extension of the Neuro-Ttr Trial

Useful Links

Get Help